Case study describes potential breakthrough in treatment of aggressive type of prostate cancer
Researchers from the George Washington University and the Washington DC Veterans Affairs Medical Center have published a case ...
Targeted Oncology18h
The Targeted Pulse: A Review of Last Month’s FDA Prominent Actions and Key Data Updates Advancing Treatment Across Disease Types
Highlights include acalabrutinib’s approval for mantle cell lymphoma, T-DXd’s priority review for HER2-low breast cancer, advances in MDS, TNBC, HCC, and perioperative lung cancer research to be ...
TheHealthSite2d
Survival Secrets: Challenges Faced By Breast Cancer Patients After Failed Chemo
After chemotherapy failure, if the cancer is also resistant to endocrine therapy, patients face a double obstacle: few ...
EurekAlert!6d
Weight loss interventions associated with improvements in several symptoms of PCOS
A systematic review of randomized controlled trials (RCTs) found that weight-loss interventions were associated with improvements in some polycystic ovary syndrome (PCOS) symptoms, including ...
oncnursingnews6d
ESMO Congress
The novel drug SHR-A1921 was safe and efficacious in patients with platinum-resistant ovarian cancer, according to phase 1 data.
oncnursingnews5d
Lung Cancer
Patients with extensive-stage small cell lung cancer tended to have better PFS and OS with complete consolidative radiotherapy compared to incomplete consolidative radiotherapy.
Targeted Oncology5d
GI CANCERS
The sponsor is preparing a phase 2 study to evaluate namodenoson in this patient population.